Bevacizumab biosimilar(Gene Techno Science)

贝伐珠单抗生物类似药（Gene Techno Science）

Report date: 2022/03/16 15:21:27

Base Information

Drug NameBevacizumab biosimilar(Gene Techno Science)
Drug Alias NameGBS-004
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Biosimilar
Mechanisms of ActionVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGene Techno Science
China Registration ClassN/A

Develop Information

Active CompaniesGene Techno Science
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A